BRISTOL-MYERS SQUIBB COMPANY |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 44.74 USD | +2.45% |
|
+2.38% | -12.80% |
| 05-09 | India's Alembic Pharma posts higher Q4 profit on strong N.America sales | RE |
| 05-07 | Ligand Pharmaceuticals Investing in Agenus to Fund Development of Oncology Drug Candidates | MT |
Presenter SpeechTimothy Power (Executives)Good morning. This is Tim Power from Bristol-Myers S...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
Bristol-Myers Squibb Company est spécialisé dans le développement, la fabrication et la commercialisation de produits pharmaceutiques. Les produits sont destinés au traitement des cancers, des maladies cardio-vasculaires, de l'hépatite, des maladies immunitaires et des désordres psychiatriques.
The United States account for 70.1% of net sales.
Sector
Pharmaceuticals
Calendar
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B
Sell
Buy
Mean consensus
HOLD
Number of Analysts
25
Last Close Price
43.67
USD
Average target price
53.19
USD
Spread / Average Target
+21.81%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -12.80% | 90.69B | |
| +32.36% | 695B | |
| +26.51% | 568B | |
| -4.40% | 361B | |
| +19.46% | 330B | |
| +3.50% | 283B | |
| +16.34% | 239B | |
| +6.68% | 204B | |
| -9.08% | 198B | |
| +8.62% | 168B |
- Stock Market
- Equities
- BMY Stock
- News Bristol-Myers Squibb Company
- Transcript : Bristol-Myers Squibb Company - Special Call